Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

In celebration of Canada’s 150th anniversary, Their Royal Highnesses, The Prince of Wales and The Duchess of Cornwall were in attendance for many festivities in Ottawa on July 1st.

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Latest News IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies February 9, 2024 Following the elections held for the position of Chair of the International […]

THE CMC 2023 COMMITTEE  CHAIR: Dr. Rowena RidoutVice Chair: Dr. Claudia Gagnon SCIENTIFIC COMMITTEE MEMBERS Dr. Rowena Ridout Dr. Claudia Gagnon Dr. Heather McDonald Blumer Dr. Heather Frame Dr. Sandra […]

The new Canada’s Food Guide was released on Tuesday Jan 22nd. It is a modern approach to promoting healthy eating, making healthier eating choices easier for all Canadians. This new […]

Dr. Mohit Bhandari, a member of the SAC Executive committee,  a Professor in the Department of Surgery at McMaster University and a leader in the field of orthopedic surgery has […]

Advocate Educate, empower and support In keeping with our mission to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis, Osteoporosis Canada communicates concerns about various […]